Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994 Sep-Oct;7(5):403-16.

The hypertensive patient in family practice

Affiliations
  • PMID: 7810356
Review

The hypertensive patient in family practice

D W Price. J Am Board Fam Pract. 1994 Sep-Oct.

Abstract

Background: Hypertension is one of the commonest reasons for visits to family physicians. Left untreated, hypertension and its sequelae can lead to serious morbidity and mortality. Most hypertensive patients have essential hypertension.

Methods: MEDLINE and Index Medicus literature searches of original studies, meta-analyses, and clinical reviews were conducted for the years 1987 to the present to review the latest recommendations on the diagnosis and treatment of hypertension. Background information from articles written before 1987, accessed from cross-reference of the more recent articles, is occasionally cited.

Results and conclusions: Based on the reviewed literature, an approach to the diagnosis and treatment of hypertension for the family physician is presented with an emphasis on cost-effectiveness and nonpharmacologic treatment. Nonpharmacologic measures and lifestyle modification should always be part of the treatment plan, especially given the presence or risks of other comorbid conditions (i.e., diabetes and stroke). Coexisting conditions, side-effects, ease of adherence, cost of medication and monitoring, and anti-left ventricular hypertrophy properties should be considered in selecting a pharmaceutical agent to treat hypertension. Several areas of further research, particularly in the areas of cost-effectiveness and outcomes, are needed to refine further the treatment of hypertension.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources